About Prestige Consumer Healthcare Inc
- Industry: Pharmaceuticals
- Exchange: NEW YORK STOCK EXCHANGE, INC.
- Country: US
- Website: https://www.prestigebrands.com/
Frequently Asked Questions
What is the 52-week range for PBH?
The 52-week high is $71.07 and the 52-week low is $42.62.
What is the P/E ratio for PBH?
The Price to Earnings (P/E) ratio is 12.55.
What is the dividend yield for PBH?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 9.22%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 15.57%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.49.
Analyst Recommendation Trends
Wall Street analyst consensus for PBH over the last few months:
Latest PBH News
Best Value Stocks to Buy for October 1st
BP and PBH made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 1, 2026.
PBH vs. NEOG: Which Stock Is the Better Value Option?
PBH vs. NEOG: Which Stock Is the Better Value Option?
More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds
Women may be talking more openly about intimate health and wellness, but that does not necessarily mean the discomfort has disappeared. New research from Summer's Eve® finds that while nearly two-thirds of U.S. women (63%) believe women today are more comfortable openly discussing intimate health and wellness than they were five years ago, more than half (52%) have personally avoided talking to someone about an intimate health and wellness concern because they felt embarrassed or uncomfortable.
Has Prestige Consumer Healthcare (PBH) Fallen Far Enough On Earnings?
Prestige Consumer Healthcare has seen its share price under pressure over the past year, and that kind of slide naturally puts the spotlight on what investors are paying for its earnings today. The question now is whether the current valuation of Prestige Consumer Healthcare's profit stream still makes sense given how the business is executing. The stock has fallen 24.2% over the past year, which raises the issue of whether the current earnings multiple properly reflects what the company is...
Prestige Consumer Healthcare (PBH) Could Be 30% Undervalued After Its 2027 Targets
Prestige Consumer Healthcare (PBH) recently outlined medium term targets for fiscal 2027, putting fresh attention on its over the counter portfolio, free cash flow priorities, and the impact of Clear Eyes supply constraints. Prestige Consumer Healthcare’s recent medium term outlook lands after a tougher stretch in the market, with the share price down 23.34% year to date and the 1 year total shareholder return declining 24.25%, while the 30 day share price return has fallen 10.56%. This...
Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow
Prestige Consumer Healthcare (NYSE:PBH) said its strategy centers on investing in established over-the-counter brands, maintaining a high-margin operating model and using free cash flow for debt reduction, acquisitions and other shareholder-value initiatives. Speaking at a fireside chat, Chief Fina
PBH or NEOG: Which Is the Better Value Stock Right Now?
PBH vs. NEOG: Which Stock Is the Better Value Option?
Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
Prestige Consumer Healthcare Inc. (PBH) Barclays 19th Annual Global Consumer Staples Conference September 10, 2026 12:45 PM EDTCompany ParticipantsRon...
Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference
TARRYTOWN, N.Y., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that Ron Lombardi, Chairman, President, & CEO and Christine Sacco, CFO and COO will participate in a fireside chat at the Barclays Global Consumer Conference on Thursday, September 10, 2026 at 12:45 p.m. ET. A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the followin
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-04 | ZIER DAWN M. | +2,981 | - | - |
| 2026-08-04 | Kelly John F. | +2,981 | - | - |
| 2026-08-04 | DArecca James | +2,981 | - | - |
| 2026-08-04 | Clark Celeste A. | +2,981 | - | - |
| 2026-08-04 | BYOM JOHN E | +2,981 | - | - |
| 2026-05-11 | Zerillo Jeffrey | -351 | $52.28 | $18,350 |
| 2026-05-07 | Zerillo Jeffrey | -305 | $54.36 | $16,580 |
| 2026-05-07 | Zerillo Jeffrey | -351 | $54.59 | $19,161 |
| 2026-05-07 | Sacco Christine | -991 | $54.59 | $54,099 |
| 2026-05-07 | Lombardi Ronald M. | -2,543 | $54.59 | $138,822 |
| 2026-05-07 | Mekhail Adel | -487 | $54.59 | $26,585 |
| 2026-05-05 | Zerillo Jeffrey | -1,207 | $54.99 | $66,373 |
| 2026-05-05 | Zerillo Jeffrey | -307 | $55.75 | $17,115 |
| 2026-05-05 | Sacco Christine | -1,267 | $55.75 | $70,635 |
| 2026-05-05 | Lombardi Ronald M. | -2,197 | $55.75 | $122,483 |
| 2026-05-05 | Zerillo Jeffrey | -346 | $55.32 | $19,141 |
| 2026-05-04 | Sacco Christine | +11,976 | - | - |
| 2026-05-04 | Sacco Christine | -3,434 | $55.31 | $189,935 |
| 2026-05-04 | Sacco Christine | +7,008 | - | - |
| 2026-05-04 | P'Pool William | +4,187 | - | - |
| 2026-05-04 | P'Pool William | -1,888 | $55.31 | $104,425 |
| 2026-05-04 | P'Pool William | +3,675 | - | - |
| 2026-05-04 | Zerillo Jeffrey | +2,857 | - | - |
| 2026-05-04 | Zerillo Jeffrey | -1,243 | $55.31 | $68,750 |
| 2026-05-04 | Zerillo Jeffrey | +2,450 | - | - |
| 2026-05-04 | Mekhail Adel | +4,014 | - | - |
| 2026-05-04 | Mekhail Adel | -1,695 | $55.31 | $93,750 |
| 2026-05-04 | Mekhail Adel | +3,505 | - | - |
| 2026-05-04 | Lombardi Ronald M. | +19,662 | - | - |
| 2026-05-04 | Lombardi Ronald M. | -16,789 | $55.31 | $928,600 |
| 2026-05-04 | Lombardi Ronald M. | +31,468 | - | - |
| 2026-05-02 | Sacco Christine | -1,091 | $55.09 | $60,103 |
| 2026-05-02 | Lombardi Ronald M. | -2,665 | $55.09 | $146,815 |
| 2026-05-02 | Sacco Christine | -1,091 | $55.09 | $60,103 |
| 2026-05-02 | Zerillo Jeffrey | -432 | $55.09 | $23,799 |
| 2026-05-02 | Mekhail Adel | -542 | $55.09 | $29,859 |
| 2026-05-02 | P'Pool William | -599 | $55.09 | $32,999 |
| 2026-02-11 | Zerillo Jeffrey | -1,000 | $65.93 | $65,930 |
| 2026-01-06 | Rosado Jose Luis | +3,426 | - | - |
| 2025-12-01 | Zerillo Jeffrey | -281 | $60 | $16,860 |
| 2025-11-28 | Zerillo Jeffrey | -719 | $60 | $43,140 |
| 2025-11-25 | BYOM JOHN E | -3,000 | $59.35 | $178,050 |